Nitec Pharma AG, of Reinach, Switzerland, appointed Anders Harfstrand CEO and Andrea Buscaglia chief financial officer...Redpoint Bio Corp., of Ewing, N.J., appointed Allen Bloom, Irwin Scher and Richard Shanley to its board...Venrock, of Menlo Park, Calif., named Steve Goldby as partner and Ken Song as vice president

The company also named Heiner Dreismann, Laurence R. McCarthy and Stuart A. Auerbach to its board of directors...The company also appointed Martin Stogniew executive vice president and chief technology officer...ProtAffin AG, of Graz, Austria, named Timothy Wells and Marco Sardinia to its scientific advisory board

Koch previously held financial and managerial positions with Eli Lilly and Co., Elan Pharmaceuticals, Zeneus Pharma and Cephalon Pharmaceuticals, among others...DBV Technologies, of Boulogne-Billancourt, France, has strengthened its management team with three new appointments and moved into larger premises...and Laurent Martin has been appointed regulatory affairs director

AEterna Zentaris Inc., of Quebec City, appointed Paul Blake senior vice president and chief medical officer...MPI Research, of Mattawan, Mich., named David Serota vice president of toxicology and pathology and Tina Rogers associate director of research...ProtoKinetix Inc., of Vancouver, British Columbia, appointed Ross L. Senior president and CEO

BioLineRx Ltd., of Jerusalem, appointed Tamar Howson, Gil Bianco and Ilan Leviteh to its board of directors...NeurAxon Inc., of Waltham, Mass., appointed Robert Medve chief medical and regulatory officer...Tikvah Therapeutics Inc., of Atlanta, named Jack W. Callicutt vice president and chief financial officer

BioLineRx Ltd., of Jerusalem, named Tamar Howson, Gil Bianco and Ilan Leviteh to its board of directors...OrthoLogic Corp., of Tempe, Ariz., appointed Michael E. Mendelsohn and Charles A. Dinarello to its scientific advisory board...Semafore Pharmaceuticals Inc., of Indianapolis, appointed Edward L. Jacobs president and chief executive officer

Med BioGene Inc., of Vancouver, British Columbia, appointed Nathan Yoganathan chief scientific advisor and appointed Bradley McLean chief scientific officer...NeurAxon Inc., of Waltham, Mass., named Lawrence E. Bloch chief executive officer and appointed him to its board of directors...OxiGene Inc., of Waltham, Mass., appointed Patricia Walicke chief medical officer and vice president

Affymax Inc., of Palo Alto, Calif., promoted Anne-Marie Duliege to chief medical officer and Christine Conroy to vice president of regulatory affairs and good clinical practice compliance...Alpha Innotech Corp., of San Leandro, Calif., named Joseph D. Keegan and Gus E. Davis to its board of directors...BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointed Stuart Grant senior vice president and chief financial officer

Diamics Inc., of Novato, Calif., appointed Piush Vidyarthi vice president of operations and business development...Micromet Inc., of Bethesda, Md., appointed Carsten Reinhardt senior vice president and chief medical officer...Phenomix Corp., of San Diego, appointed James Harper and William Harris to its board of directors

Anacor Pharmaceuticals, of Palo Alto, Calif., appointed Christine Gray-Smith senior vice president and chief financial officer...ViroPharma Inc., of Exton, Pa., appointed Thierry Darcis vice president and general manager of ViroPharma Europe...The company also named Richard Bax vice president of clinical development and medical affairs for ViroPharma Europe

Aspreva Pharmaceuticals Corp., of Victoria, Canada, named J. William Freytag, chairman and chief executive officer...Bavarian Nordic AS, of Kvistgard, Denmark, named Anders Hedegaard president and chief executive officer...Orexigen Therapeutics Inc., of San Diego, appointed Heather Turner vice president and general counsel

MedImmune Inc., of Gaithersburg, Md., named William K. Wang director of research and development...Novavax Inc., of Rockville, Md., appointed Len Stigliano vice president, chief financial officer and treasurer...ZymoGenetics Inc., of Seattle, named Douglas E. Williams president of the company and promoted James A. Johnson to executive vice president

Synarc Inc., of San Francisco, appointed Jeffrey Bairstow executive vice president and chief financial officer...TheraQuest Biosciences, of Blue Bell, Pa., appointed Cynthia McCormick and Nathaniel Katz to its scientific advisory board...Trimeris Inc., of Morrisville, N.C., named Stephen Davis and Barry Quart to its board of directors

Nucryst Pharmaceuticals, of Akefield, Mass., named Katherine Turner vice president of research and development...Progen Pharmaceuticals Ltd., of Brisbane, Australia, named Rene Adam, Pei-Jer Chen, Gail Eckhardt, Philip Johnson, Sung-Gye Lee, Ronnie Poon, Myron Schwartz, William Sievert and Tadatoshi Takayama to its international clinical advisory board to support the clinical development and commercialization of PI-88 in the treatment of post-resection liver cancer

Bionovo Inc., of Emeryville, Calif., named Tom Chesterman senior vice president and chief financial officer...The company also named Keane and Elliot M. Maza to its board of directors...Merrimack Pharmaceuticals Inc., of Cambridge, Mass., named Lisa Evren senior vice president and chief financial officer

Oculus Innovative Sciences Inc., of Petaluma, Calif., named Dana Redhair vice president of regulatory affairs and quality...Presidio Pharmaceuticals Inc., of San Francisco, named Marcus Conant chief medical officer and Antoun Nabhan chief financial officer

Ardea Biosciences Inc., of Carlsbad, Calif., appointed John Beck and John Poyhonen to its board of directors...vice president of research and development and chief scientific officer

Progen Pharmaceuticals, of Brisbane, Australia, appointed James Garner vice president of medical and clinical affairs, and John Devlin vice president of manufacturing operations...Seattle Genetics, of Bothell, Wash., added John P. McLaughlin and Daniel G. Welch to its board of directors...Zogenix Inc., of San Diego, appointed David Nassif executive vice president and chief financial officer

Roger Ganser, acting CEO, has retired and will continue as chairman of the board of directors...Chromatin also appointed Caroline Kovac and John Hamer to its board of directors...Metabolix Inc., of Cambridge, Mass., named George Kipouras and Kristin Taylor business development managers, and Debra Darby brand director